Literature DB >> 19903743

MicroRNAs in ovarian carcinomas.

Neetu Dahiya1, Patrice J Morin.   

Abstract

The molecular mechanisms involved in epithelial ovarian cancer initiation and progression are just beginning to be elucidated. In particular, it has become evident that microRNAs (miRNAs or miRs), a class of molecules that post-transcriptionally regulate gene expression, play a major role in ovarian tumorigenesis. Several microRNA profiling studies have identified changes in microRNA patterns that take place during ovarian cancer development. While most deregulated microRNAs are down-regulated in cancer, and may therefore act as tumor suppressors, others are elevated and may represent novel oncogenes in this disease. A number of microRNAs identified as aberrantly expressed in ovarian carcinoma have been shown to have important functional roles in cancer development and may therefore represent targets for therapy. In addition, some of the microRNA patterns may have prognostic significance. The identification of functional targets represents a major hurdle in our understanding of microRNA function in ovarian carcinoma, but significant progress is being made. It is hoped that a better understanding of the microRNA expression and roles in ovarian cancer may provide new avenues for the detection, diagnosis, and therapy of this deadly disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19903743      PMCID: PMC2856347          DOI: 10.1677/ERC-09-0203

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  92 in total

1.  A microRNA cluster as a target of genomic amplification in malignant lymphoma.

Authors:  H Tagawa; M Seto
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

2.  The deep evolution of metazoan microRNAs.

Authors:  Benjamin M Wheeler; Alysha M Heimberg; Vanessa N Moy; Erik A Sperling; Thomas W Holstein; Steffen Heber; Kevin J Peterson
Journal:  Evol Dev       Date:  2009 Jan-Feb       Impact factor: 1.930

3.  A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions.

Authors:  Chad J Creighton; Ankur K Nagaraja; Samir M Hanash; Martin M Matzuk; Preethi H Gunaratne
Journal:  RNA       Date:  2008-09-23       Impact factor: 4.942

4.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

5.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs.

Authors:  Ren-Jun Hsu; Hsin-Jung Yang; Huai-Jen Tsai
Journal:  Nucleic Acids Res       Date:  2009-05-06       Impact factor: 16.971

8.  Fertility preservation in young women with epithelial ovarian cancer.

Authors:  Jason D Wright; Monjri Shah; Leny Mathew; William M Burke; Jennifer Culhane; Noah Goldman; Peter B Schiff; Thomas J Herzog
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

9.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

10.  Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors:  Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more
  44 in total

Review 1.  [Pathobiology of the microRNA system].

Authors:  K Hussein
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

2.  HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.

Authors:  Jingjing Wu; Zhaojian Liu; Changshun Shao; Yaoqin Gong; Eva Hernando; Peng Lee; Masashi Narita; William Muller; Jinsong Liu; Jian-Jun Wei
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

3.  Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells.

Authors:  Dhwanil Damania; Hemant K Roy; Dhananja Kunte; Jean A Hurteau; Hariharan Subramanian; Lusik Cherkezyan; Nela Krosnjar; Maitri Shah; Vadim Backman
Journal:  Int J Cancer       Date:  2013-04-01       Impact factor: 7.396

4.  miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.

Authors:  Y Lv; Y Lei; Y Hu; W Ding; C Zhang; C Fang
Journal:  Clin Transl Oncol       Date:  2015-06-24       Impact factor: 3.405

5.  A syntenic locus on buffalo chromosome 20: novel genomic hotspot for miRNAs involved in follicular-luteal transition.

Authors:  Vijay Simha Baddela; Suneel Kumar Onteru; Dheer Singh
Journal:  Funct Integr Genomics       Date:  2016-11-19       Impact factor: 3.410

6.  miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.

Authors:  Bruna Rodrigues Muys; Josane F Sousa; Jessica Rodrigues Plaça; Luíza Ferreira de Araújo; Aishe A Sarshad; Dimitrios G Anastasakis; Xiantao Wang; Xiao Ling Li; Greice Andreotti de Molfetta; Anelisa Ramão; Ashish Lal; Daniel Onofre Vidal; Markus Hafner; Wilson A Silva
Journal:  Cancer Res       Date:  2019-05-17       Impact factor: 12.701

7.  MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.

Authors:  Xiaotang Yu; Xinchen Zhang; Tie Bi; Yanfang Ding; Jinyao Zhao; Chang Wang; Tingting Jia; Dan Han; Gordon Guo; Bo Wang; Jiyong Jiang; Shiying Cui
Journal:  Tumour Biol       Date:  2013-07-09

8.  miR-197-3p reduces epithelial-mesenchymal transition by targeting ABCA7 in ovarian cancer cells.

Authors:  Weiquan Xie; Chengyu Shui; Xiping Fang; Yuqiu Peng; Li Qin
Journal:  3 Biotech       Date:  2020-08-04       Impact factor: 2.406

9.  MiR-338-3p targets pyruvate kinase M2 and affects cell proliferation and metabolism of ovarian cancer.

Authors:  Yuting Zhang; Bing Shi; Jiang Chen; Lina Hu; Chunquan Zhao
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

10.  MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.

Authors:  Hirosha Geekiyanage; Evanthia Galanis
Journal:  Mol Oncol       Date:  2016-07-28       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.